Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Submitted by
admin
on August 23, 2017 - 11:14am
Source:
Yahoo/Zacks.com
News Tags:
Pfizer
Ibrance
breast cancer
Faslodex
AstraZeneca
Headline:
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Do Not Allow Advertisers to Use My Personal information
